CALVEX A/S

Their core work

Calvex A/S is a Danish agri-tech SME based in Skive that developed milkGUARD, a continuous whole-milk disinfection system designed for on-farm calf feeding. Their product addresses a concrete animal husbandry problem: calves fed raw bulk milk are exposed to pathogens including Mycobacterium avium subsp. paratuberculosis (Johne's disease), Salmonella, and other bacteria present in unsold milk. Rather than relying on conventional pasteurization, Calvex engineered an in-line, continuous disinfection solution that integrates directly into calf milk feeders at farm level. They followed the classic EU SME Instrument pathway — Phase 1 feasibility study in 2017, then a full Phase 2 innovation project from 2018 to 2021 — indicating a product-driven company pushing a single technology toward commercial readiness.

What they specialise in

How they've shifted over time

Calvex's entire H2020 history spans just two years (2017–2018 start dates) and represents a single product at two stages of development rather than a shift in research direction. Phase 1 (2017) was a feasibility and market study for the milkGUARD concept; Phase 2 (2018) was the full innovation project to bring that same product to commercial maturity. There is no detectable pivot or broadening of scope — this is a company that identified one problem, committed fully to solving it, and executed a focused commercialisation pathway. Future collaborations, if any, would likely extend the same milk-hygiene or precision livestock technology into adjacent areas such as automated calf feeders or broader biosecurity systems on dairy farms.

Calvex is a single-product SME that has completed its EU-funded development arc; the next logical step would be market rollout, licensing, or technology transfer — making them a potential commercial partner rather than a new R&D collaborator.

How they like to work

Calvex led both of their EU projects as coordinator, with a minimal consortium of just one partner in one country — a configuration typical of SME Instrument projects, which are designed for company-driven innovation with limited consortium overhead. This is not an organisation that builds large multi-partner networks; they engage external expertise selectively and maintain tight project control. A potential collaborator should expect to work closely with the company's core team on a well-defined technical scope rather than within a broad research network.

Calvex has worked with only one unique partner across both projects, all within a single country — an unusually narrow network even by SME Instrument standards. Their geographic and collaborative reach is effectively local, concentrated on executing a defined product development task rather than building European research relationships.

What sets them apart

Calvex occupies a very specific niche: continuous in-line milk disinfection at the point of calf feeding, which is distinct from bulk-tank pasteurisation and from automated calf feeders without hygiene systems. Within Denmark — one of Europe's most intensive dairy farming nations — this positions them to address a practical on-farm problem that affects calf mortality and antibiotic use. For a consortium builder, they offer rare applied expertise in dairy biosecurity hardware backed by completed EU-funded validation, not just a research concept.

Highlights from their portfolio

• MilkGuard
  The largest project (€1.065M, 2018–2021) represents a full Phase 2 SME Instrument award — the most competitive EU SME funding tier — confirming that an independent evaluation panel judged the milkGUARD technology commercially viable and investment-worthy.
• milkGUARD
  The Phase 1 feasibility project (2017, €50k) demonstrates disciplined product development process: Calvex validated market and technical feasibility before committing to full-scale development, a sign of structured innovation management for an SME.